Olema signs 7-year lease for new HQ space
Olema Pharmaceuticals, Inc. entered a seven-year lease with KR Oyster Point II, LLC for a new headquarters totaling approximately 38,176 square feet across two floors in South San Francisco.
Rhea-AI Filing Summary
Olema Pharmaceuticals, Inc. entered a seven-year lease with KR Oyster Point II, LLC for a new headquarters totaling approximately 38,176 square feet across two floors in South San Francisco. The company plans to relocate its corporate headquarters to this space by December 2026 as existing San Francisco leases expire between December 2026 and January 2027.
The Lease sets total base rent of $12,361,188.00 for Phase I and $6,145,463.76 for Phase II during the initial term, net of rent abatement. Olema must provide a cash security deposit of $427,546.80 and may terminate once at month 60 by paying a $1,716,240.96 fee. The agreement includes a five-year extension option and a right of first offer on additional space, while the landlord funds specified build-out work and can terminate if Olema fails to cure certain breaches.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 1.01, 2.03
2 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Key Figures
Total leased area: 38,176 square feet
Phase I area: 25,048 square feet
Phase II area: 13,128 square feet
+5 more
8 metrics
Total leased area
38,176 square feet
Combined Phase I and Phase II premises
Phase I area
25,048 square feet
Fourth floor space under the lease
Phase II area
13,128 square feet
Fifth floor space under the lease
Phase I base rent
$12,361,188.00
Total base rent over initial term, net of abatement
Phase II base rent
$6,145,463.76
Total base rent over initial term, net of abatement
Termination fee
$1,716,240.96
Fee to terminate at end of 60th full month
Security deposit
$427,546.80
Cash security deposit required under the lease
Initial lease term
7 years
Initial Term of the lease agreement
Key Terms
Material Definitive Agreement, Initial Term, rent abatement, right of first offer, +2 more
6 terms
Material Definitive Agreement regulatory
"Item 1.01 Entry into a Material Definitive Agreement."
A material definitive agreement is a legally binding contract that creates major, long‑term obligations or rights for a company, such as loans, asset sales, mergers, or supplier deals. Think of it like a mortgage or lease for a business: it can change future cash flow, risk and control, so investors watch these agreements closely because they can materially affect a company’s value, financial health and stock price.
Initial Term financial
"The initial term of the Lease is seven years (the “Initial Term”)"
rent abatement financial
"total base rent for Phase I during the Initial Term, net of rent abatement"
A temporary reduction or suspension of rent a tenant must pay, negotiated into a lease or granted by a landlord for a set period or specific circumstances. It matters to investors because it directly changes a property owner’s rental income and cash flow—like a short-term discount or payment pause—and can affect valuation, debt coverage, and a tenant’s ability to stay in place during repairs, fit-outs, or financial strain.
right of first offer financial
"a right of first offer to expand the size of the Premises"
A right of first offer is a contractual agreement that requires an owner to offer an asset or stake to a designated party before marketing it to others; the holder gets the first chance to negotiate terms directly with the seller. For investors, it matters because it can limit who can buy or set the sale price path—like getting the first invitation to buy a sought-after item before it goes on general sale, protecting potential access or controlling competition.
operating expenses financial
"the Company to pay its pro rata share of operating expenses and certain taxes"
Operating expenses are the routine costs a company pays to keep its business running day to day — things like salaries, rent, utilities, office supplies, and marketing. Investors watch them because they reduce the profit available to shareholders and reveal how efficiently a company runs; lower or well-controlled operating expenses (relative to revenue) are like trimming household bills to improve savings.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What lease agreement did Olema Pharmaceuticals (OLMA) enter into?
Olema Pharmaceuticals entered a seven-year lease with KR Oyster Point II, LLC for 38,176 square feet of office and lab space, split between two floors, intended to become its new corporate headquarters as current San Francisco leases approach expiration in late 2026 and early 2027.
How much space is Olema Pharmaceuticals (OLMA) leasing at its new headquarters?
Olema is leasing approximately 38,176 square feet in total, including 25,048 square feet on the fourth floor (Phase I) and 13,128 square feet on the fifth floor (Phase II). This combined area is expected to accommodate the company’s future headquarters and related operations.
What are the base rent commitments in Olema Pharmaceuticals’ new lease?
The lease provides total base rent of $12,361,188.00 for Phase I and $6,145,463.76 for Phase II over the initial seven-year term, net of rent abatement. These amounts reflect Olema’s core rental obligations, excluding its share of operating expenses, taxes, assessments, and related fees.
What options and termination rights does Olema Pharmaceuticals (OLMA) have under the lease?
Olema has a one-time right to terminate the lease after the 60th full month of the initial term by paying a $1,716,240.96 termination fee. The company also holds an option to extend the lease for an additional five-year period, subject to the lease’s conditions.
When will Olema’s new lease phases commence and when is relocation expected?
Phase I is expected to commence around September 15, 2026, and Phase II around December 1, 2026, tied to occupancy or delivery conditions. Olema intends to relocate its corporate headquarters to the new premises by December 2026, aligning with the expiration of current leases.
What additional financial obligations does Olema Pharmaceuticals have under the new lease?
Beyond base rent, Olema must provide a $427,546.80 cash security deposit and pay its pro rata share of operating expenses, taxes, assessments, and related fees. The landlord funds specified build-out work, while Olema remains responsible for ongoing obligations defined in the lease terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
